An interview with Dr. Randy Taplitz from UC San Diego Health on the guideline update which addresses antimicrobial prophylaxis for adult patients with immunosuppression associated with cancer and its ...

The following represents disclosure information provided by authors of this manuscript. All relationships are considered compensated. Relationships are self-held unless noted. I = Immediate Family ...

A total of 24 patients (14 ALL, 3 AML, 3 DLBCL, 3 Burkitt and 1 T-cell lymphoblastic lymphoma) was prophylaxed with at least one dose of liposomal cytarabine over an 8-year period from 2004 to 2012.

Invasive fungal disease (IFD), and particularly invasive aspergillosis, is a challenging cause of morbidity and mortality in patients undergoing alloSCT. 1, 2 Many studies, mainly from ...

"We know definitively that we can prevent almost all bleeding – decreasing bleeding frequency by > 90% as well as the severity of bleeding episodes – by continuing prophylaxis into adulthood or ...

Please provide your email address to receive an email when new articles are posted on . “We know that UTIs are one of the most common infections leading to hospitalization, and recurrent UTIs are ...

Study authors examined 186,589 patients with an initial positive urine culture and receiving antibiotics to quantify risks and benefits of UTI prophylaxis in older adults. Long-term antibiotic urinary ...

WOBURN, Mass.--(BUSINESS WIRE)--ROMEG Therapeutics, an innovative drug development company focused on alternative formulations to better meet clinical and patient needs, today announced that the U.S.

With Gift Aid, your generous donation of £10 would be worth £12.50 at no extra cost to you. Yes, I want to Gift Aid any donations made to NAM now, in the future and in the past four years I am a UK ...

WHAT: Astellas Pharma US, Inc. ("Astellas"), a U.S. subsidiary of Tokyo-based Astellas Pharma Inc. (Tokyo: 4503), announced today that ASTAGRAF XL TM (tacrolimus extended-release capsules) for the ...